Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 Vaccination Before and After CD19-targeted CAR T-cell Immunotherapy
NCT04745559Phase 2Active, not recruiting
- Sponsor
- Moffitt Cancer Center
- Start
- Feb 2021
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Prevnar 13 in pneumococcal infection, sponsored by Moffitt Cancer Center. Started Feb 2021; status: active, not recruiting.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT04745559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04745559.